Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
PUT
Revvity
RVTY
$14.4B
| $4.12M | ﹤0.01% |
28,700
+8,900
| +45% | +$1.18M |
|
|
LOGC
3702
PUT
DELISTED
ContextLogic
LOGC
| $4.12M | ﹤0.01% |
+7,523
| New | +$4.64M |
|
3703
PUT
Cardiff Oncology
CRDF
$73.1M
| $4.11M | ﹤0.01% |
228,700
+128,400
| +128% | +$2.26M |
|
|
LAC
3704
PUT
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $4.11M | ﹤0.01% |
327,800
+174,300
| +114% | +$1.96M |
|
3705
PUT
Globant
GLOB
$1.75B
| $4.11M | ﹤0.01% |
18,900
+6,200
| +49% | +$1.2M |
|
|
SOL
3706
DELISTED
Emeren Group
SOL
| $4.11M | ﹤0.01% |
359,236
+348,784
| +3,337% | +$1.9M |
|
3707
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.26B
| $4.1M | ﹤0.01% |
61,875
+50,287
| +434% | +$2.44M |
|
3708
Welltower
WELL
$172B
| $4.1M | ﹤0.01% |
63,482
+74
| +0.1% | +$4.49K |
|
|
NVRO
3709
PUT
DELISTED
NEVRO CORP.
NVRO
| $4.1M | ﹤0.01% |
23,700
-25,600
| -52% | -$4.15M |
|
3710
PUT
BioCryst Pharmaceuticals
BCRX
$2.51B
| $4.1M | ﹤0.01% |
550,100
-111,700
| -17% | -$576K |
|
3711
Vanguard Information Technology ETF
VGT
$147B
| $4.1M | ﹤0.01% |
92,640
+40,344
| +77% | +$1.66M |
|
3712
PUT
Snap-on
SNA
$20.3B
| $4.09M | ﹤0.01% |
23,900
-10,700
| -31% | -$1.79M |
|
|
CCMP
3713
PUT
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $4.08M | ﹤0.01% |
27,000
-8,700
| -24% | -$1.3M |
|
3714
Entergy
ETR
$49.3B
| $4.08M | ﹤0.01% |
81,784
+42,676
| +109% | +$2.25M |
|
|
RVNC
3715
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.08M | ﹤0.01% |
144,063
+117,736
| +447% | +$3.05M |
|
3716
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $4.08M | ﹤0.01% |
72,573
+34,065
| +88% | +$1.87M |
|
3717
PUT
Celanese
CE
$4.94B
| $4.08M | ﹤0.01% |
31,400
-127,800
| -80% | -$15.9M |
|
3718
Howmet Aerospace
HWM
$106B
| $4.08M | ﹤0.01% |
142,966
-59,314
| -29% | -$1.32M |
|
3719
Ingersoll Rand
IR
$30.5B
| $4.08M | ﹤0.01% |
89,524
-95,533
| -52% | -$3.95M |
|
3720
Eversource Energy
ES
$26.7B
| $4.08M | ﹤0.01% |
47,136
+12,585
| +36% | +$1.12M |
|
3721
CALL
Federal Realty Investment Trust
FRT
$10.1B
| $4.08M | ﹤0.01% |
47,900
-36,300
| -43% | -$3.02M |
|
|
IBTX
3722
CALL
DELISTED
Independent Bank Group, Inc.
IBTX
| $4.08M | ﹤0.01% |
65,200
-10,000
| -13% | -$553K |
|
3723
Meritage Homes
MTH
$4.63B
| $4.07M | ﹤0.01% |
98,288
+81,536
| +487% | +$3.85M |
|
3724
Global X Uranium ETF
URA
$6.39B
| $4.07M | ﹤0.01% |
265,466
+94,066
| +55% | +$1.15M |
|
3725
Agilent Technologies
A
$43.4B
| $4.06M | ﹤0.01% |
34,253
+27,893
| +439% | +$3.09M |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.